Artificial intelligence continues to reshape biotechnology, enabling faster and more accurate diagnostics, personalized therapeutics, and innovative drug discovery. Breakthroughs include a new AI medical imaging tool requiring minimal data for training, and machine learning models to enhance immunotherapy for metastatic lung cancer. Significant investments are driving development of AI platforms targeting complex diseases, while AI aids in novel protein design and precision medicine initiatives. These advancements promise to transform clinical workflows and treatment outcomes.